These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 13695106

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The effect of 5-hydroxytryptamine and of monoamine oxidase inhibitors on sexual maturity.
    ROBSON JM, BOTROS M.
    J Endocrinol; 1961 Apr; 22():165-75. PubMed ID: 13742374
    [No Abstract] [Full Text] [Related]

  • 24. Reversal of the reserpine-induced depletion of brain serotonin by a monoamine oxidase inhibitor.
    CANAL N, MAFFEI-FACCIOLI A.
    J Neurochem; 1959 Dec; 5():99-100. PubMed ID: 13807360
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Blood pressure and respiration behavior after the administration of serotonin into the cisterna magna with the simultaneous application of monoamine oxidase inhibitors].
    KRAWCZYK J.
    Acta Physiol Pol; 1960 Dec; 11():788-9. PubMed ID: 13754150
    [No Abstract] [Full Text] [Related]

  • 29. [Monoamine liberators and monoamine oxidase inhibitors].
    LEUSEN I.
    Psychiatr Neurol (Basel); 1960 Jul; 140():154-64. PubMed ID: 13761295
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Metastasizing carcinoid and 5-hydroxytryptamine.
    JENSEN K.
    Dan Med Bull; 1957 May; 4(3):96-101. PubMed ID: 13437704
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Interaction of monoamine oxidase inhibitors with physiological and biochemical mechanisms in brain.
    BRODIE BB, SPECTOR S, SHORE PA.
    Ann N Y Acad Sci; 1959 Sep 17; 80():609-16. PubMed ID: 13804624
    [No Abstract] [Full Text] [Related]

  • 36. Recent biochemical developments with monoamine oxidase inhibitors.
    SHORE PA.
    Dis Nerv Syst; 1960 Mar 17; 21(3)Suppl():62-3. PubMed ID: 14446179
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Monoamine oxidase inhibition.
    ROSENBLUM I, FERGUSON FC.
    Clin Pharmacol Ther; 1960 Mar 17; 1():692-3. PubMed ID: 13743428
    [No Abstract] [Full Text] [Related]

  • 40. [Biochemical and pharmacological aspects of nialamide and comparison of it with other monoamine oxidase inhibitors (MAO)].
    NUNEZ-OLARTE E.
    Rev Fac Med Univ Nac Colomb; 1960 Mar 17; 28():107-13. PubMed ID: 13729907
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.